홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Potassium Carbonate → 2-{(2S)-2-[4-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-morpholin-4-yl}-1H-[4,4']bipyrimidinyl-6-one

HRID 2045908
인쇄

반응식

HRID 2045908 반응식
Cl.[CH3:2][C:3]1[O:7][N:6]=[C:5]([C:8]2[CH:13]=[CH:12][C:11]([C@@H:14]3[O:19][CH2:18][CH2:17][NH:16][CH2:15]3)=[CH:10][CH:9]=2)[N:4]=1.Cl.[N:21]1([C:26](N)=[NH:27])C=CC=N1.C(N(CC)C(C)C)(C)C.C(O[C:41](=[O:51])[CH2:42][C:43](=O)[C:44]1[CH:49]=[CH:48][N:47]=[CH:46][N:45]=1)C.C(=O)([O-])[O-].[K+].[K+]>CN(C)C=O.C(O)C>[CH3:2][C:3]1[O:7][N:6]=[C:5]([C:8]2[CH:13]=[CH:12][C:11]([C@@H:14]3[O:19][CH2:18][CH2:17][N:16]([C:26]4[NH:27][C:41](=[O:51])[CH:42]=[C:43]([C:44]5[CH:49]=[CH:48][N:47]=[CH:46][N:45]=5)[N:21]=4)[CH2:15]3)=[CH:10][CH:9]=2)[N:4]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 11430Potassium CarbonateHCID 81531DiisopropylethylamineHCID 2734672Pyrazole-1-carboxamidine monohydrochlorideHCID 11961458Ethyl 3-oxo-3-(pyrimidin-4-yl)propanoateHCID 66603801(2S)-2-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)morpholine hydrochloride2회

생성물 1

HCID 135910186
2-{(2S)-2-[4-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-morpholin-4-yl}-1H-[4,4']bipyrimidinyl-6-one
수율 33%

시약·촉매·용매 2

HCID 702Ethanol용매HCID 6228Dimethylformamide용매

실험 절차

To a solution of (2S)-2-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)morpholine hydrochloride (intermediate 13, 4.00 g, 14.2 mmol) and 1H-pyrazole-1-carboxamidine hydrochloride (2.19 g, 14.9 mmol) in N,N-dimethylformamide (14 ml) was added. N,N-diisopropylethylamine (4.05 g, 31.3 mmol) at room temperature and the solution was stirred for 4 hours. The solution was decanted with ether, then 3-oxo-3-pyrimidin-4-yl-propionic acid ethyl ester (3.59 g, 18.5 mmol), potassium carbonate (4.92 g, 35.6 mmol) and ethanol (30 ml) were added to the resulting solution. After refluxed for 18 hours, the solution was concentrated under reduced pressure. The residue was washed with water and the hot mixture of ethanol and 1N hydrochloric acid (1/1, v/v), and dried under reduced pressure to afford 2-{(2S)-2-[4-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-morpholin-4-yl}-1H-[4,4′]bipyrimidinyl-6-one (1.94 g, 33%).

후처리

  1. customThe solution was decanted with ether
  2. temperatureAfter refluxed for 18 hours
  3. concentrationthe solution was concentrated under reduced pressure
  4. washThe residue was washed with water
  5. additionthe hot mixture of ethanol and 1N hydrochloric acid (1/1
  6. customv/v), and dried under reduced pressure

출처 및 근거

ORD 기록
ord-698c32bb8c254a46a4c1c5a7996f0d20
출처 데이터셋
uspto-grants-2013_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08592417B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트